Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 0.00 | 794.77K | 1.86M | 209.73K | 16.68K |
Gross Profit | 0.00 | 598.02K | 1.07M | 102.58K | 16.68K |
EBITDA | -168.05K | -3.19M | -1.25M | -8.12M | -4.83M |
Net Income | -60.84K | -3.19M | -1.25M | -8.83M | -5.34M |
Balance Sheet | |||||
Total Assets | 20.73K | 28.13K | 3.00M | 3.88M | 5.53M |
Cash, Cash Equivalents and Short-Term Investments | 1.92K | 17.13K | 154.36K | 1.21M | 1.72M |
Total Debt | 100.88K | 171.36K | 125.00K | 60.00K | 0.00 |
Total Liabilities | 523.45K | 587.73K | 553.71K | 1.28M | 940.67K |
Stockholders Equity | -502.73K | -559.60K | 2.45M | 2.60M | 4.59M |
Cash Flow | |||||
Free Cash Flow | -59.72K | -118.59K | -644.00K | -2.12M | -3.92M |
Operating Cash Flow | -59.72K | -118.59K | -644.00K | -2.12M | -3.92M |
Investing Cash Flow | 0.00 | -65.00K | -435.00K | -843.00K | -192.00K |
Financing Cash Flow | 44.52K | 46.36K | 25.00K | 2.45M | 5.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
60 Neutral | $43.84B | 1.71 | -10.46% | 3.98% | 2.32% | -37.93% | |
51 Neutral | C$1.12M | ― | -319.69% | ― | -86.68% | -58.90% | |
― | C$940.37K | 2.50 | ― | ― | ― | ||
― | C$2.98M | ― | ― | ― | ― | ||
― | C$622.30K | ― | ― | ― | ― | ||
― | C$1.49M | ― | ― | ― | ― | ||
― | C$614.72K | ― | ― | ― | ― |
AlphaGen Intelligence Corp. has announced a non-brokered private placement offering of up to 7,137,000 common shares at $0.12 per share, aiming to raise up to $856,440. The proceeds from this offering are intended for general working capital, with the closing expected around August 11, 2025, pending regulatory approvals. This move is set to bolster AlphaGen’s financial flexibility, potentially enhancing its operational capabilities and market positioning.
AlphaGen Intelligence Corp. announced the completion of a debt settlement transaction by issuing over 2.25 million common shares to settle outstanding debts, including a significant amount to its CFO, Eli Dusenbury. This move is part of the company’s strategic financial management, potentially impacting its market capitalization and stakeholder interests, while adhering to regulatory exemptions for related party transactions.
AlphaGen Intelligence Corp. has announced a proposed debt settlement to address $329,370 in outstanding debts by issuing 2,251,330 common shares at a price of $0.1463 per share. This transaction, which involves a related party due to the participation of CFO Eli Dusenbury, is set to close around July 10, 2025, pending regulatory approvals. The settlement is expected to strengthen the company’s financial position and demonstrates its strategic approach to managing liabilities, potentially enhancing its market standing and investor confidence.
AlphaGen Intelligence Corp. has announced a non-brokered private placement offering of up to $195,000 through the issuance of 2,437,500 units at $0.08 per unit. Each unit includes a common share and a warrant, with proceeds intended for general working capital. The offering is subject to regulatory approvals and is expected to close by May 16, 2025, potentially strengthening AlphaGen’s financial position and operational capabilities.